Search by Drug Name or NDC

    NDC 65862-0113-99 Hydrochlorothiazide 12.5 mg/1 Details

    Hydrochlorothiazide 12.5 mg/1

    Hydrochlorothiazide is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Aurobindo Pharma Limited. The primary component is HYDROCHLOROTHIAZIDE.

    Product Information

    NDC 65862-0113
    Product ID 65862-113_392abd0f-3897-4b56-acfe-6775bc175075
    Associated GPIs 37600040000110
    GCN Sequence Number 029832
    GCN Sequence Number Description hydrochlorothiazide CAPSULE 12.5 MG ORAL
    HIC3 R1F
    HIC3 Description THIAZIDE AND RELATED DIURETICS
    GCN 34820
    HICL Sequence Number 003649
    HICL Sequence Number Description HYDROCHLOROTHIAZIDE
    Brand/Generic Generic
    Proprietary Name Hydrochlorothiazide
    Proprietary Name Suffix n/a
    Non-Proprietary Name Hydrochlorothiazide
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form CAPSULE
    Route ORAL
    Active Ingredient Strength 12.5
    Active Ingredient Units mg/1
    Substance Name HYDROCHLOROTHIAZIDE
    Labeler Name Aurobindo Pharma Limited
    Pharmaceutical Class Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA078164
    Listing Certified Through 2024-12-31

    Package

    NDC 65862-0113-99 (65862011399)

    NDC Package Code 65862-113-99
    Billing NDC 65862011399
    Package 1000 CAPSULE in 1 BOTTLE (65862-113-99)
    Marketing Start Date 2007-09-19
    NDC Exclude Flag N
    Pricing Information N/A